Medics should plan ahead for incidental findings
By Erika Check Hayden,
Nature News
| 12. 12. 2013
Doctors, researchers and companies should expect to find information they were not looking for in genetic analyses, imaging scans and other tests, concludes a report from the US Presidential Commission for the Study of Bioethical Issues. Moreover, medics and investigators should discuss with patients and research volunteers how these potentially serious findings will be handled before the tests are carried out.
The advice given by the report echoes previous recommendations in specific fields. Still, researchers say it is a useful summary of basic overarching principles for grappling with 'incidental findings' that occur when a test ordered for one purpose uncovers information about another, unrelated health risk.
“They get to the heart of what needs to be done, and there is a need to codify this,” says James Evans, a geneticist at the University of North Carolina in Chapel Hill, of the panel's recommendations.
Although incidental findings have always occurred in medicine and research, the rise of more omniscient tests that can reveal large amounts of information about a person’s risk factors have posed urgent ethical questions about how to...
Related Articles
It’s been a busy couple of months in biopolitics, with developments in the US, UK, China, Japan, and implicitly on Mars. Time for a brief roundup.
• • •
Bioethics needs an update
The National Research Act is now 50 years old. It was signed into law on July 12, 1974, as a direct response to publicity about the 1932 “Tuskegee Study of Untreated Syphilis in the Negro Male.” The Hastings Bioethics Forum celebrated its anniversary with an...
Image courtesy National Human Genome Research Institute
The U.S. Food and Drug Administration (FDA) is supposed to encourage effective medical advances while also ensuring that patients and research subjects are protected. This dual mandate demands tricky judgment calls that are made more difficult by outside pressures of several kinds, political, judicial, and especially commercial. This April story at Bloomberg examines one deeply troubling pattern of regulatory capture:
Americans Are Paying Billions to Take Drugs That Don’t Work
Companies are increasingly...
By Elizabeth Chuck, NBC News | 07.09.2024
A Netflix docuseries has put a spotlight on the unregulated world of sperm donation, particularly the lack of stopgap measures that might prevent donors who have been banned by one country from simply going elsewhere to donate more.
Released earlier...
By Amanda Becker and Shefali Luthra, The 19th | 07.08.2024
Image by Duke University Archives from Flickr
Republicans have adopted a slate of policy positions ahead of next week’s convention that does not call for a federal legislative abortion ban, but opens the door to establishing fetal personhood.
The Republican...